Donated plasma benefits COVID-19 patients in small U.S. study – Severskiy (News)

Patients with severe COVID-19 given plasma from someone who recovered from the disease were more likely to stabilize or need less oxygen support than other similar hospital patients, according to results of a small U.S. study released on Friday.

The study showed a trend toward better survival rates, but the number of patients was small and the results cannot be interpreted as applying to patients on mechanical ventilators, researchers at New York’s Mt. Sinai Medical Center said.

Mt. Sinai analyzed outcomes for 39 hospitalized patients with severe COVID-19 who received convalescent plasma transfusions compared to outcomes for patients with carefully matched medical status.

“This is a retrospective case-controlled study. It does not have the rigor of a randomized, controlled trial so that still needs to be done,” Dr. Nicole Bouvier, an infectious disease specialist at Mt. Sinai and the study’s lead author, told Reuters.

“This does show promise that convalescent plasma is effective.”

Nearly 70% of the 39 patients were on high-flow oxygen and 10% were on mechanical ventilation. After two weeks, the disease worsened in 18% of the plasma patients and 24% of the control patients.

As of May 1, nearly 13% of plasma recipients had died, compared with more than 24% of the control patients, with 72% and 67%, respectively, being discharged alive.

People who survive an infectious disease like COVID-19 are left with blood containing antibodies, or proteins made by the body’s immune system to fight off a virus. The blood component that carries the antibodies can be collected and given to newly infected patients – it is known as “convalescent plasma.”

Hospitals around the world have been using plasma donated by recovered COVID-19 patients, but there has been little information on how effective the treatment is.

The U.S. Food and Drug Administration on May 1 gave emergency approval to Gilead Sciences Inc’s antiviral drug remdesivir for COVID-19 based on data showing that it reduced hospitalization time by 31% compared to a placebo, but did not have a significant effect on survival.

The post Donated plasma benefits COVID-19 patients in small U.S. study appeared first on Reuters.

Similar Articles

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Study: Effectiveness of cloth masks depends on type of covering

Months into the COVID-19 pandemic, wearing a mask while out in public has become the recommended practice. However, many still question the effectiveness of...

Archaeology: Cooling of Earth caused by eruptions, not meteors

IMAGE: Workers excavating Hall's Cave in Central Texas ...

Nanotechnology: Sharing a secret…the quantum way

IMAGE: An artistic impression sharing a secret using structured...

Medicine: Insight on novel genetic approaches to metabolic liver diseases

DETROIT - Diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affects over...

Diseases: Targetable biological mechanisms implicated in emergent psychiatric conditions associated with SARS-CoV-2

What The Viewpoint Says: Targetable biological mechanisms implicated in emergent psychiatric conditions associated with SARS-CoV-2 infection are discussed in this Viewpoint. Authors: Teodor T. Postolache, M.D., of...

Science: Policies to mitigate wildfire impacts have public health implications, amplified amid COVID

As the western United States enters the 2020 wildfire season with anticipated above normal significant fire potential, a new report from Physicians, Scientists,...